Objectives: 

1.Review the new concentrated insulins approved by the FDA.

2.Review the upcoming addition of U-500 regular insulin to the University of Chicago Medicine formulary.

3.Understand when and how to transition patients in the hospital to reduce the risk of significant dysglycemia.

Session date: 
02/20/2017 - 12:00pm to 1:00pm CST
Location: 
UCMC W-300
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Celeste Thomas, MD MS